Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001600546-14-000001
Filing Date
2014-02-21
Accepted
2014-02-21 16:49:57
Documents
1
Effectiveness Date
2014-02-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6834
  Complete submission text file 0001600546-14-000001.txt   7912
Mailing Address 405 LEXINGTON AVENUE 34TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 34TH FLOOR NEW YORK NY 10174 212-226-7348
Bienville Health Science Partners, LP (Filer) CIK: 0001600546 (see all company filings)

EIN.: 463910030 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-212335 | Film No.: 14634271